Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...
The U.S. continues to charge significantly higher prices for prescription drugs compared with similarly wealthy countries.
Several large drugmakers, including Pfizer, Bristol Myers Squibb and Sanofi, increased the list prices of their drugs this ...
Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs.
While the New Year's tradition of drug price hikes has held firm for years, pharma companies have decidedly tamped down on ...
The top 10 patented drugs getting expired in the coming years in the US, include Pembrolizumab, sold under the brand name ...
More than 250 medications, including Paxlovid and cancer therapies, will see price increases in the United States beginning ...